NKARTA INC. - COMMON STOCK

Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2

05 ديسمبر 2024 05:01:00 بحسب Nasdaq GlobeNewswire

Nkarta to Participate in an Upcoming Investor Conference

26 نوفمبر 2024 06:02:00 بحسب Nasdaq GlobeNewswire

Nkarta to Participate in an Upcoming Investor Conference

12 نوفمبر 2024 07:02:00 بحسب Nasdaq GlobeNewswire

Nkarta Reports Third Quarter 2024 Financial Results and Corporate Highlights

07 نوفمبر 2024 15:02:00 بحسب Nasdaq GlobeNewswire

Nkarta to Participate in Upcoming Investor Conference

03 سبتمبر 2024 15:01:00 بحسب Nasdaq GlobeNewswire

Correction: Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights

13 أغسطس 2024 20:03:42 بحسب Nasdaq GlobeNewswire

Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights

13 أغسطس 2024 15:01:00 بحسب Nasdaq GlobeNewswire

Nkarta Announces Initiation of Investigator-Sponsored Clinical Trial Evaluating NKX019 for Systemic Lupus Erythematosus

24 يوليو 2024 05:00:00 بحسب Nasdaq GlobeNewswire

Nkarta Announces Leadership Updates, Appoints Nadir Mahmood as President

16 يوليو 2024 05:01:00 بحسب Nasdaq GlobeNewswire

Nkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Announces Pipeline Expansion to Additional Autoimmune Indications

27 يونيو 2024 05:00:00 بحسب Nasdaq GlobeNewswire

Nkarta Adds Experienced Leader in Autoimmune R&D, George Vratsanos, M.D., FACR, to Board of Directors

13 يونيو 2024 15:01:00 بحسب Nasdaq GlobeNewswire

Nkarta Reports First Quarter 2024 Financial Results and Corporate Highlights

09 مايو 2024 15:01:00 بحسب Nasdaq GlobeNewswire

Nkarta to Participate in Upcoming Investor Conferences

03 أبريل 2024 15:02:00 بحسب Nasdaq GlobeNewswire

Nkarta Announces Pricing of $240 Million Underwritten Offering

25 مارس 2024 05:30:00 بحسب Nasdaq GlobeNewswire

Nkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights

21 مارس 2024 15:01:00 بحسب Nasdaq GlobeNewswire

Nkarta to Participate in Upcoming Investor Conferences

28 فبراير 2024 07:01:00 بحسب Nasdaq GlobeNewswire

Nkarta Presents NKX101 Clinical Data at the 2023 American Society of Hematology Annual Meeting & Exposition

09 ديسمبر 2023 19:31:00 بحسب Nasdaq GlobeNewswire

Nkarta Reports Third Quarter 2023 Financial Results and Corporate Highlights

09 نوفمبر 2023 15:02:00 بحسب Nasdaq GlobeNewswire

Nkarta to Participate at Upcoming Investor Conferences

07 نوفمبر 2023 07:02:00 بحسب Nasdaq GlobeNewswire

Nkarta Receives FDA Clearance of IND Application for NKX019 in Lupus Nephritis

17 أكتوبر 2023 06:01:00 بحسب Nasdaq GlobeNewswire